WAM
IRD

Warberg Asset Management’s Opus Genetics IRD Stock Holding History

Warberg Asset Management’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,000
Closed -$9.82K – 230
2025
Q1 		$9.82K Buy
+10,000
New +$11.2K ﹤0.01% 152
2022
Q4 		– Sell
-21,000
Closed -$42K – 306
2022
Q3 		$42K Sell
21,000
-3,200
-13% -$6.9K 0.01% 179
2022
Q2 		$46K Buy
+24,200
New +$55K 0.01% 151

Other funds holding IRD

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Warberg Asset Management's IRD Position: Q2 2025 in Review

Warberg Asset Management sold out of Opus Genetics (IRD) in Q2 2025, closing a stake of 10,000 shares — an estimated $9.82K sold.

Warberg Asset Management first reported a position in IRD in Q2 2022 and held it in 3 quarters. The position peaked at $46K in Q2 2022. 43 funds tracked by Wall St. Rank hold IRD as of Q2 2025.

  • Warberg Asset Management reported no remaining Opus Genetics position as of Q2 2025 after selling out during the quarter.
  • Warberg Asset Management sold 10,000 Opus Genetics shares in Q2 2025, an estimated $9.82K.
  • Warberg Asset Management first reported a position in Opus Genetics in Q2 2022 and held it in 3 quarters.
  • Warberg Asset Management's Opus Genetics position peaked at $46K in Q2 2022.
  • 43 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2025.

Based on Warberg Asset Management's 13F filing for Q2 2025, filed 12 Aug 2025.